Autolus Therapeutics Plc logo

Autolus Therapeutics Plc share price today

(AUTL)

Autolus Therapeutics Plc share price is $2.35 & ₹201.28 as on 1 Jan 2025, 2.30 'hrs' IST

$2.35

0.14

(6.33%)

Market is closed - opens 8 PM, 02 Jan 2025

View live Autolus Therapeutics Plc share price in Dollar and Rupees. Guide to invest in Autolus Therapeutics Plc from India. Also see the sentimental analysis on Indian investors investing in Autolus Therapeutics Plc. Get details on the Indian mutual funds that are investing in Autolus Therapeutics Plc. Get Analyst recommendations and forecasts along with all the Autolus Therapeutics Plc's financials.

Autolus Therapeutics Plc share price movements

  • Today's Low: $2.23
    Today's High: $2.35

    Day's Volatility :5.11%

  • 52 Weeks Low: $2.07
    52 Weeks High: $7.45

    52 Weeks Volatility :72.21%

Autolus Therapeutics Plc Returns

PeriodAutolus Therapeutics PlcSector (Health Care)Index (Russel 2000)
3 Months
-39.74%
-10.0%
0.0%
6 Months
-31.88%
-4.7%
0.0%
1 Year
-64.45%
-0.9%
0.0%
3 Years
-56.96%
-2.4%
-21.2%

Autolus Therapeutics Plc Key Statistics

in dollars & INR

Previous Close
$2.21
Open
$2.24
Today's High
$2.35
Today's Low
$2.23
Market Capitalization
$625.4M
Today's Volume
$900.8K
52 Week High
$7.45
52 Week Low
$2.07
Revenue TTM
$10.1M
EBITDA
$-205.9M
Earnings Per Share (EPS)
$-1.22
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-82.2%

How to invest in Autolus Therapeutics Plc from India?

It is very easy for Indian residents to invest directly in Autolus Therapeutics Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Autolus Therapeutics Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Autolus Therapeutics Plc or AUTL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Autolus Therapeutics Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Autolus Therapeutics Plc shares which would translate to 0.364 fractional shares of Autolus Therapeutics Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Autolus Therapeutics Plc, in just a few clicks!

Returns in Autolus Therapeutics Plc for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Autolus Therapeutics Plc investment value today

Current value as on today

₹38,419

Returns

₹61,581

(-61.58%)

Returns from Autolus Therapeutics Plc Stock

₹64,448 (-64.45%)

Dollar Returns

₹2,867 (+2.87%)

Indian investors sentiment towards Autolus Therapeutics Plc

-59%

Period: Oct 3, 2024 to Jan 1, 2025. Change in 30 Days versus previous period

Search volume for Autolus Therapeutics Plc on INDmoney from India has reduced in the last 30 days as on Jan 2, 2025. -59% less investors are searching Autolus Therapeutics Plc in the last 30 days versus the previous period.

Global Institutional Holdings in Autolus Therapeutics Plc

  • Wellington Management Company LLP

    9.10%

  • Blackstone Inc

    7.70%

  • Syncona Portfolio Ltd.

    6.97%

  • FMR Inc

    6.68%

  • Deep Track Capital, LP

    5.74%

  • venBio Select Advisor LLC

    4.64%

Analyst Recommendation on Autolus Therapeutics Plc

Buy

    82%Buy

    17%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Autolus Therapeutics Plc(by analysts ranked 0 to 5 stars)

Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
14
14
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Autolus Therapeutics Plc

What analysts predicted

Upside of 344.68%

Current:

$2.35

Target:

$10.45

Insights on Autolus Therapeutics Plc

  • Price Movement

    In the last 1 month, AUTL stock has moved down by -27.9%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 406.0K → 10.09M (in $), with an average increase of 79.8% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -52.69M → -82.09M (in $), with an average decrease of 25.7% per quarter
  • AUTL vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 20.7% return, outperforming this stock by 86.3%
  • AUTL vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.8% return, outperforming this stock by 93.5%
  • Price to Sales

    ForAUTL every $1 of sales, investors are willing to pay $54.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Autolus Therapeutics Plc Technicals Summary

Sell

Neutral

Buy

Autolus Therapeutics Plc is currently in a neutral trading position according to technical analysis indicators.

Autolus Therapeutics Plc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Autolus Therapeutics Plc
-26.56%
-31.88%
-64.45%
-56.96%
-81.84%
Regeneron Pharmaceuticals, Inc.
-4.97%
-31.12%
-22.37%
13.59%
91.62%
Biontech Se
-1.42%
42.28%
3.53%
-50.85%
155.61%
Alnylam Pharmaceuticals, Inc.
-6.56%
-6.26%
23.43%
35.31%
102.91%
Vertex Pharmaceuticals Incorporated
-11.88%
-15.14%
-1.95%
80.96%
79.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Autolus Therapeutics Plc
NA
NA
NA
-0.92
-0.82
-0.22
NA
1.79
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Autolus Therapeutics Plc
Buy
$625.4M
-81.84%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
91.62%
17.61
33.61%
Biontech Se
Buy
$27.3B
155.61%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
102.91%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
79.75%
32.84
-4.51%

About Autolus Therapeutics Plc

autolus is a private biopharmaceutical company, focused on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. we are building a leading biotechnology company focussed on the development and commercialisation of engineered t-cell therapies for haematological and solid tumours. autolus has the ambition to be a leader of a revolution in medicine in which life-threatening diseases are treated by a patient’s own cells.
Organization
Autolus Therapeutics Plc
Employees
463
CEO
Dr. Christian Martin Itin Ph.D.
Industry
Health Technology

Management People of Autolus Therapeutics Plc

NameTitle
Dr. Christian Martin Itin Ph.D.
CEO & Director
Dr. Martin Pule M.D., MBBS
Founder, Senior VP & Chief Scientific Officer
Mr. Robert F. Dolski
Senior VP & CFO
Mr. Christopher Vann
Senior VP & COO
Mr. David Brochu
Senior VP & Chief Technical Officer
Mr. Alexander Swan
Senior VP & Chief Human Resources Officer
Mr. Brent Rice
Senior VP, Chief Commercial Officer & Site Head of US
Ms. Olivia Manser
Director of Investor Relations
Mr. Alex Driggs
Senior VP of Legal Affairs & General Counsel and Secretary
Dr. Chris Williams
Chief Business Officer

Important FAQs about investing in Autolus Therapeutics Plc from India :

What is Autolus Therapeutics Plc share price today?

Autolus Therapeutics Plc share price today stands at $2.35, Open: $2.24 ; Previous Close: $2.21 ; High: $2.35 ; Low: $2.23 ; 52 Week High: $7.45 ; 52 Week Low: $2.07. The stock opens at $2.24, after a previous close of $2.21. The stock reached a daily high of $2.35 and a low of $2.23, with a 52-week high of $7.45 and a 52-week low of $2.07.

Can Indians buy Autolus Therapeutics Plc shares?

Yes, Indians can invest in the Autolus Therapeutics Plc (AUTL) from India.

With INDmoney, you can buy Autolus Therapeutics Plc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Autolus Therapeutics Plc at zero transaction cost.

How can I buy Autolus Therapeutics Plc shares from India?

It is very easy to buy Autolus Therapeutics Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Autolus Therapeutics Plc be purchased?

Yes, you can buy fractional shares of Autolus Therapeutics Plc with INDmoney app.

What are the documents required to start investing in Autolus Therapeutics Plc stocks?

To start investing in Autolus Therapeutics Plc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Autolus Therapeutics Plc

Today’s highest price of Autolus Therapeutics Plc (AUTL) is $2.35.

Today’s lowest price of Autolus Therapeutics Plc (AUTL) is $2.23.

What is today's market capitalisation of Autolus Therapeutics Plc

Today's market capitalisation of Autolus Therapeutics Plc AUTL is 625.4M

What is the 52 Week High and Low Range of Autolus Therapeutics Plc

  • 52 Week High

    $7.45

  • 52 Week Low

    $2.07

What are the historical returns of Autolus Therapeutics Plc?

  • 1 Month Returns

    -26.56%

  • 3 Months Returns

    -31.88%

  • 1 Year Returns

    -64.45%

  • 5 Years Returns

    -81.84%

Who is the Chief Executive Officer (CEO) of Autolus Therapeutics Plc

Dr. Christian Martin Itin Ph.D. is the current Chief Executive Officer (CEO) of Autolus Therapeutics Plc.